1. Liu T, Zhang X, Korantzopoulos P, Wang S, Li G. Uric Acid Levels and Atrial Fibrillation in Hypertensive Patients. Internal Medicine. 2011;50(8):799–803. DOI: 10.2169/internalmedicine.50.4587
2. Hamaguchi S, Furumoto T, Tsuchihashi-Makaya M, Goto K, Goto D, Yokota T et al. Hyperuricemia predicts adverse outcomes in patients with heart failure. International Journal of Cardiology. 2011;151(2):143–7. DOI: 10.1016/j.ijcard.2010.05.002
3. Yamada S, Suzuki H, Kamioka M, Kamiyama Y, Saitoh S-I, Takeishi Y. Uric Acid Increases the Incidence of Ventricular Arrhythmia in Patients with Left Ventricular Hyperthrophy. Fukushima Journal of Medical Science. 2012;58(2):101–6. DOI: 10.5387/fms.58.101
4. Chen Y, Wu S, Li W, Wang B, Lv H, Yang X et al. Gender-Related Association of Serum Uric Acid Levels with Premature Ventricular Contraction. International Heart Journal. 2018;59(6):1246–52. DOI: 10.1536/ihj.17-474
5. Nodera M, Suzuki H, Matsumoto Y, Kamioka M, Kaneshiro T, Yoshihisa A et al. Association between Serum Uric Acid Level and Ventricular Tachyarrhythmia in Heart Failure Patients with Implantable Cardioverter-Defibrillator. Cardiology. 2018;140(1):47–51. DOI: 10.1159/000488851
6. Özyılmaz S, Satılmışoğlu MH, Gül M, Uyarel H, Serdar A. Assessment of the Association Between serum Uric Acid level and the Predicted Risk Score of Sudden Cardiac Death at Five Years in Patients with Hypertrophic Cardiomyopathy. Turk Kardiyoloji Dernegi Arsivi. 2017;46(2):111–20. DOI: 10.5543/tkda.2017.60094
7. Tamariz L, Harzand A, Palacio A, Verma S, Jones J, Hare J. Uric Acid as a Predictor of All-Cause Mortality in Heart Failure: A Meta-Analysis. Congestive Heart Failure. 2011;17(1):25–30. DOI: 10.1111/j.1751-7133.2011.00200.x
8. Giannopoulos G, Angelidis C, Deftereos S. Gout and arrhythmias: In search for causation beyond association. Trends in Cardiovascular Medicine. 2019;29(1):41–7. DOI: 10.1016/j.tcm.2018.06.004
9. Srivastava A, Kaze AD, McMullan CJ, Isakova T, Waikar SS. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD. American Journal of Kidney Diseases. 2018;71(3):362–70. DOI: 10.1053/j.ajkd.2017.08.017
10. Deng Y, Liu F, Yang X, Xia Y. The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation. Frontiers in Cardiovascular Medicine. 2021;8: 641136. DOI: 10.3389/fcvm.2021.641136
11. Letsas KP, Korantzopoulos P, Filippatos GS, Mihas CC, Markou V, Gavrielatos G et al. Uric acid elevation in atrial fibrillation. Hellenic journal of cardiology. 2010;51(3):209–13. PMID: 20515852
12. Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. Uric Acid, Left Ventricular Mass Index, and Risk of Cardiovascular Disease in Essential Hypertension. Hypertension. 2006;47(2):195–202. DOI: 10.1161/01.HYP.0000200033.14574.14
13. Radovanovic S, Savic-Radojevic A, Pekmezovic T, Markovic O, Memon L, Jelic S et al. Uric Acid and Gamma-glutamyl Transferase Activity Are Associated with Left Ventricular Remodeling Indices in Patients with Chronic Heart Failure. Revista Española de Cardiología (English Edition). 2014;67(8):632–42. DOI: 10.1016/j.rec.2013.11.017
14. Chen C-C, Hsu Y-J, Lee T-M. Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia. American Journal of Physiology-Heart and Circulatory Physiology. 2011;301(3):H1107–17. DOI: 10.1152/ajpheart.01071.2010
15. Canton M, Menazza S, Sheeran FL, Polverino de Laureto P, Di Lisa F, Pepe S. Oxidation of Myofibrillar Proteins in Human Heart Failure. Journal of the American College of Cardiology. 2011;57(3):300–9. DOI: 10.1016/j.jacc.2010.06.058
16. Sovari AA, Iravanian S, Dolmatova E, Jiao Z, Liu H, Zandieh S et al. Inhibition of c-Src Tyrosine Kinase Prevents Angiotensin II–Mediated Connexin-43 Remodeling and Sudden Cardiac Death. Journal of the American College of Cardiology. 2011;58(22):2332–9. DOI: 10.1016/j.jacc.2011.07.048
17. De Boer RA, Lok DJA, Jaarsma T, van der Meer P, Voors AA, Hillege HL et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Annals of Medicine. 2011;43(1):60–8. DOI: 10.3109/07853890.2010.538080
18. Özyılmaz S. Assessment of the association between the presence of fragmented QRS and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy. The Anatolian Journal of Cardiology. 2017;18(1):54–61. DOI: 10.14744/AnatolJCardiol.2017.7593
19. Qin L, Yang Z, Gu H, Lu S, Shi Q, Xing Y et al. Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals. BMC Cardiovascular Disorders. 2014;14(1):26. DOI: 10.1186/1471-2261-14-26
20. Nakanishi N, Li W, Fukuda H, Takatorige T, Suzuki K, Tatara K. Multiple Risk Factor Clustering and Risk of Hypertension in Japanese Male Office Workers. Industrial Health. 2003;41(4):327–31. DOI: 10.2486/indhealth.41.327
21. Sun G-Z, Guo L, Wang J, Ye N, Wang X-Z, Sun Y-X. Association between hyperuricemia and atrial fibrillation in rural China: a cross-sectional study. BMC Cardiovascular Disorders. 2015;15(1):98. DOI: 10.1186/s12872-015-0089-y
22. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. American Journal of Epidemiology. 1995;141(7):637–44. DOI: 10.1093/oxfordjournals.aje.a117479
23. Levine W, Dyer A, Shekelle R, Schoenberger J, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: Findings of the Chicago heart association detection project in industry. Journal of Clinical Epidemiology. 1989;42(3):257–67. DOI: 10.1016/0895-4356(89)90061-9
24. Singh JA, Cleveland J. Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data. BMC Medicine. 2017;15(1):59. DOI: 10.1186/s12916-017-0816-6